Kisses From Italy Announces Rapid Expansion and New Leadership After Regen Health Merger

The company is pivoting into the high-growth biologics and longevity sector with a focus on regenerative medicine and peptide therapy.

Apr. 16, 2026 at 7:37pm

A minimalist studio still life featuring a collection of sleek, polished medical devices and wellness products arranged on a clean, monochromatic background, conceptually representing the advanced regenerative treatments and longevity-focused care offered by Regen Health Physicians.Kisses From Italy's pivot into the high-growth biologics and longevity sector aims to meet rising consumer demand for precision-driven regenerative care and personalized wellness solutions.NYC Today

Kisses From Italy Inc. (KITL) has unveiled an aggressive 2026 expansion strategy and new leadership following its business combination with Regen Health Physicians. The company is appointing Dr. Ajit Dhaliwal, MD, MBA, as its new CEO to drive innovation, brand elevation, and national expansion initiatives. KITL is positioning itself for rapid national scale by leveraging Regen Health's proven medical platform, expanding its clinic footprint, and pursuing growth through targeted acquisitions.

Why it matters

The merger with Regen Health Physicians marks a transformative entry for KITL into the high-growth biologics and longevity sector. Regenerative medicine, anti-aging therapies, and personalized wellness solutions are seeing surging global demand as consumers focus more on longevity, performance optimization, and preventative care. KITL is uniquely positioned to capitalize on this momentum by combining clinical expertise with a scalable, growth-oriented infrastructure.

The details

KITL plans to rapidly scale revenues and establish a recognized premium healthcare brand across the United States. The company will leverage Regen Health's proven medical platform, expand its clinic footprint, and pursue growth through targeted acquisitions. Regen Health Physicians specialize in precision-driven regenerative care, offering advanced biologic therapies, regenerative treatments, and peptide-based therapies to support healing, repair tissue, and restore function.

  • KITL unveiled its expansion strategy and new leadership on April 16, 2026.
  • The company plans to open initial operational clinics in major markets like New York City and Salt Lake City, with Miami and San Francisco in its sights.

The players

Kisses From Italy Inc.

A publicly listed U.S.-based company that is transitioning from a restaurant chain developer and franchisor to the aesthetic wellness space, a fast-growing field for women and men's biologics and related types of care.

Dr. Ajit Dhaliwal, MD, MBA

The new CEO of KITL, who has been appointed to lead the company's transformative chapter. Dr. Dhaliwal has extensive experience in the healthcare industry, including building and exiting a previous healthcare company.

Regen Health Physicians

A medical platform that specializes in precision-driven regenerative care, offering advanced biologic therapies, regenerative treatments, and peptide-based therapies.

Viktorija Ivinskas

The Managing Director of KITL's subsidiary Kinetic Integrated Wellness Group, who brings expertise in medical aesthetics, biologics, longevity, and luxury wellness brands.

James W. Zimbler

The President, CEO, and Director of Kisses From Italy Inc.

Got photos? Submit your photos here. ›

What they’re saying

“I am incredibly excited to step into the role of CEO and lead this transformative chapter for KITL. When Jim and I first discussed this combination, what struck me immediately was the alignment - a publicly traded platform ready for a bold new direction, and a proven clinical model built to scale. Regenerative medicine and aesthetic wellness are not just trends; they are the future of how Americans will approach their health.”

— Dr. Ajit Dhaliwal, Chief Executive Officer, Regen Health Physicians

What’s next

KITL is also working on completing its year-end disclosure filing as soon as possible.

The takeaway

The merger between Kisses From Italy and Regen Health Physicians represents a strategic pivot for KITL into the high-growth biologics and longevity sector. By leveraging Regen Health's proven medical platform and expertise in regenerative medicine and peptide therapy, KITL is positioning itself to capitalize on the surging global demand for anti-aging treatments, personalized wellness solutions, and preventative care.